Events

At Lightcast we are developing a novel, programmable microfluidic platform that allows precise and highly flexible control of individual microdroplets using software-generated light patterns. Our massively parallel capability (10K – 100K+ droplets) will enable higher screening capacity, allowing rare events to be detected such as antibodies for challenging targets. By merging droplets containing different cell types, reporters and /or other reagents, the system can perform complex workflows with stepwise assays and sequential readouts with great flexibility. This has the potential to both accelerate functional characterisation and shorten optimisation time in Antibody Discovery and Cell Therapy workflows. Please register here and come and learn more about Lightcast over lunch and meet the team!